Cargando…

HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects

BACKGROUND: The microbiome is essential to immune development, defense against pathogens, and modulation of inflammation. Microbial dysbiosis has been reported in various diseases including human immunodeficiency virus (HIV) and opioid use disorder (OUD). Notably, people living with HIV (PLWH) have...

Descripción completa

Detalles Bibliográficos
Autores principales: Satish, Sanjana, Abu, Yaa, Gomez, Daniel, Kumar Dutta, Rajib, Roy, Sabita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164749/
https://www.ncbi.nlm.nih.gov/pubmed/37168868
http://dx.doi.org/10.3389/fimmu.2023.1156862
_version_ 1785038122210295808
author Satish, Sanjana
Abu, Yaa
Gomez, Daniel
Kumar Dutta, Rajib
Roy, Sabita
author_facet Satish, Sanjana
Abu, Yaa
Gomez, Daniel
Kumar Dutta, Rajib
Roy, Sabita
author_sort Satish, Sanjana
collection PubMed
description BACKGROUND: The microbiome is essential to immune development, defense against pathogens, and modulation of inflammation. Microbial dysbiosis has been reported in various diseases including human immunodeficiency virus (HIV) and opioid use disorder (OUD). Notably, people living with HIV (PLWH) have been reported to both have higher rates of OUD and use opioids at higher rates than the general public. Thus, studying gut microbial alterations in people living with HIV and with OUD could elucidate mechanisms pertaining to how these conditions both shape and are shaped by the microbiome. However, to date few studies have investigated how HIV and OUD in combination impact the microbiome. AIM OF REVIEW: Here, we review previous studies outlining interactions between HIV, opioid use, and microbial dysbiosis and describe attempts to treat this dysbiosis with fecal microbial transplantation, probiotics, and dietary changes. KEY SCIENTIFIC CONCEPTS OF REVIEW: While the limited number of studies prevent overgeneralizations; accumulating data suggest that HIV and opioid use together induce distinct alterations in the gut microbiome. Among the three existing preclinical studies of HIV and opioid use, two studies reported a decrease in Lachnospiraceae and Ruminococcaceae, and one study reported a decrease in Muribaculaceae in the combined HIV and opioid group relative to HIV-alone, opioid-alone, or control groups. These bacteria are known to modulate immune function, decrease colonic inflammation, and maintain gut epithelial barrier integrity in healthy individuals. Accordingly, modulation of the gut microbiome to restore gut homeostasis may be attempted to improve both conditions. While mixed results exist regarding treating dysbiosis with microbial restoration in PLWH or in those with opioid dependency, larger well-defined studies that can improve microbial engraftment in hosts hold much promise and should still be explored.
format Online
Article
Text
id pubmed-10164749
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101647492023-05-09 HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects Satish, Sanjana Abu, Yaa Gomez, Daniel Kumar Dutta, Rajib Roy, Sabita Front Immunol Immunology BACKGROUND: The microbiome is essential to immune development, defense against pathogens, and modulation of inflammation. Microbial dysbiosis has been reported in various diseases including human immunodeficiency virus (HIV) and opioid use disorder (OUD). Notably, people living with HIV (PLWH) have been reported to both have higher rates of OUD and use opioids at higher rates than the general public. Thus, studying gut microbial alterations in people living with HIV and with OUD could elucidate mechanisms pertaining to how these conditions both shape and are shaped by the microbiome. However, to date few studies have investigated how HIV and OUD in combination impact the microbiome. AIM OF REVIEW: Here, we review previous studies outlining interactions between HIV, opioid use, and microbial dysbiosis and describe attempts to treat this dysbiosis with fecal microbial transplantation, probiotics, and dietary changes. KEY SCIENTIFIC CONCEPTS OF REVIEW: While the limited number of studies prevent overgeneralizations; accumulating data suggest that HIV and opioid use together induce distinct alterations in the gut microbiome. Among the three existing preclinical studies of HIV and opioid use, two studies reported a decrease in Lachnospiraceae and Ruminococcaceae, and one study reported a decrease in Muribaculaceae in the combined HIV and opioid group relative to HIV-alone, opioid-alone, or control groups. These bacteria are known to modulate immune function, decrease colonic inflammation, and maintain gut epithelial barrier integrity in healthy individuals. Accordingly, modulation of the gut microbiome to restore gut homeostasis may be attempted to improve both conditions. While mixed results exist regarding treating dysbiosis with microbial restoration in PLWH or in those with opioid dependency, larger well-defined studies that can improve microbial engraftment in hosts hold much promise and should still be explored. Frontiers Media S.A. 2023-04-24 /pmc/articles/PMC10164749/ /pubmed/37168868 http://dx.doi.org/10.3389/fimmu.2023.1156862 Text en Copyright © 2023 Satish, Abu, Gomez, Kumar Dutta and Roy https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Satish, Sanjana
Abu, Yaa
Gomez, Daniel
Kumar Dutta, Rajib
Roy, Sabita
HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
title HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
title_full HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
title_fullStr HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
title_full_unstemmed HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
title_short HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
title_sort hiv, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164749/
https://www.ncbi.nlm.nih.gov/pubmed/37168868
http://dx.doi.org/10.3389/fimmu.2023.1156862
work_keys_str_mv AT satishsanjana hivopioiduseandalterationstothegutmicrobiomeelucidatingindependentandsynergisticeffects
AT abuyaa hivopioiduseandalterationstothegutmicrobiomeelucidatingindependentandsynergisticeffects
AT gomezdaniel hivopioiduseandalterationstothegutmicrobiomeelucidatingindependentandsynergisticeffects
AT kumarduttarajib hivopioiduseandalterationstothegutmicrobiomeelucidatingindependentandsynergisticeffects
AT roysabita hivopioiduseandalterationstothegutmicrobiomeelucidatingindependentandsynergisticeffects